Skip to Main Content

Author Details

Cynthia J Girman
University of North Carolina at Chapel Hill
1993
203
64
PMIDPaper TitleJournal TitlePublished Year
37830395Characterizing Imbalance in the Tails of the Propensity Score Distribution.Am J Epidemiol2024
38085458Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration: An Industry Survey.Patient2024
36456851CYP2D6 Substrate Dispensing Among Patients Dispensed Mirabegron: An Administrative Claims Analysis.Drugs Real World Outcomes2023
37592153Strategy for Generating Blinded Evidence for Single-Arm Trials with External Controls Using Expert Review of Home Video.Ther Innov Regul Sci2023
37798219Can Weight of Evidence, Quantitative Bias, and Bounding Methods Evaluate Robustness of Real-world Evidence for Regulator and Health Technology Assessment Decisions on Medical Interventions?Clin Ther2023
37219800Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive Bladder.Drugs Real World Outcomes2023
35173802Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic review.Therap Adv Gastroenterol2022
35505471Alternative analytic and matching approaches for the prevalent new-user design: A simulation study.Pharmacoepidemiol Drug Saf2022
35471704Real-world data: Assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products.Pharmacoepidemiol Drug Saf2022
35635646Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.Adv Ther2022
35421820Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER-medicare study.Cancer Treat Res Commun2022
34921665Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR.Adv Ther2022
33098213Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis.Neurourol Urodyn2021
33507517Demonstrating that Real World Evidence Is Fit-For-Purpose to Support Labeling: Parallels to Patient Reported Outcomes in the Pursuit of Labeling Claims.Ther Innov Regul Sci2021
33658769Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life.Patient Prefer Adherence2021
34537953Efficacy of Vibegron and Mirabegron for Overactive Bladder: A Systematic Literature Review and Indirect Treatment Comparison.Adv Ther2021
33377193Using propensity scores to estimate effects of treatment initiation decisions: State of the science.Stat Med2021
31250380Symptoms and Dietary Impact in Hypertriglyceridemia-Associated Pancreatitis: Development and Content Validity of Two New Measures.Pharmacoecon Open2020
32072597Masking in Pragmatic Trials: Who, What, and When to Blind.Ther Innov Regul Sci2020
33258098Evaluating the Feasibility of Electronic Health Records and Claims Data Sources for Specific Research Purposes.Ther Innov Regul Sci2020
32642965Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors.Adv Ther2020
30515910Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary.Pharmacoepidemiol Drug Saf2019
29733448Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG).Clin Pharmacol Ther2018
29039693Variation in adherence to medications across the healthcare system in two comparative effectiveness research cohorts.J Comp Eff Res2017
28321981Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants.Diabetes Obes Metab2017
26950853Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium.PLoS One2016
27181564Regression coefficient-based scoring system should be used to assign weights to the risk index.J Clin Epidemiol2016
26860956Comparison of diagnostic evaluations for cough among initiators of angiotensin converting enzyme inhibitors and angiotensin receptor blockers.Pharmacoepidemiol Drug Saf2016
25390030Sensitivity analysis of methods for active surveillance of acute myocardial infarction using electronic databases.Epidemiology2015
30222392Unique Challenges in Development, Psychometric Evaluation, and Interpretation of Daily and Event Diaries as Endpoints in Clinical Trials.Ther Innov Regul Sci2015
26509706Trends and Determinants of Oral Anti-Diabetic Initiation in Youth with Suspected Type 2 Diabetes.PLoS One2015
26112690Matching on the disease risk score in comparative effectiveness research of new treatments.Pharmacoepidemiol Drug Saf2015
23949560Differential associations of oral glucose tolerance test-derived measures of insulin sensitivity and pancreatic β-cell function with coronary artery calcification and microalbuminuria in type 2 diabetes.Diabetes Care2014
25350797From mechanism to empiricism: the evolution of heterogeneity of treatment effects.J Comp Eff Res2014
24969153Pre-study feasibility and identifying sensitivity analyses for protocol pre-specification in comparative effectiveness research.J Comp Eff Res2014
25143475The role of prediction modeling in propensity score estimation: an evaluation of logistic regression, bCART, and the covariate-balancing propensity score.Am J Epidemiol2014
24374422Assessing the impact of propensity score estimation and implementation on covariate balance and confounding control within and across important subgroups in comparative effectiveness research.Med Care2014
24139354Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.Urology2014
22023802Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.Eur J Prev Cardiol2013
24386469Use of systems biology approaches to analysis of genome-wide association studies of myocardial infarction and blood cholesterol in the nurses' health study and health professionals' follow-up study.PLoS One2013
23574104Recent trends in the characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large U.S. claims database.Int J Clin Pract2013
23070806Variable selection for propensity score models when estimating treatment effects on multiple outcomes: a simulation study.Pharmacoepidemiol Drug Saf2013
21909804Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration.Qual Life Res2012
22738801Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.Curr Med Res Opin2012
22865700Integrating genetic association, genetics of gene expression, and single nucleotide polymorphism set analysis to identify susceptibility Loci for type 2 diabetes mellitus.Am J Epidemiol2012
22831166Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk.Diabetes Obes Metab2012
22212966Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.Mayo Clin Proc2012
22233166Nocturia is associated with an increased risk of coronary heart disease and death.BJU Int2012
22386420Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.Urology2012
22017349Risk of acute renal failure in patients with Type 2 diabetes mellitus.Diabet Med2012
  • 1 - 50 of 203

Recommended Authors

University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
Loyola University
Career Start Year 2010
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 2008
Number of shared co-authors 0
Center for Observational Research
Career Start Year 2006
Number of shared co-authors 18
University of Maryland School of Medicine
Career Start Year 2005
Number of shared co-authors 6
Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System
Career Start Year 2005
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 2
university of california los angeles Center for Health Sciences
Career Start Year 2001
Number of shared co-authors 1
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 3
David Geffen School of Medicine, University of California los angeles
Career Start Year 2001
Number of shared co-authors 0
Oakland University William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 1
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 2
Rocky Mountain VA Medical Center
Career Start Year 1997
Number of shared co-authors 1
Stanford University
Career Start Year 1997
Number of shared co-authors 2
Medical University of South Carolina
Career Start Year 1996
Number of shared co-authors 5
The University of Hong Kong
Career Start Year 1996
Number of shared co-authors 1
The University of Kansas Medical Center
Career Start Year 1996
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Rush University Medical Center
Career Start Year 1995
Number of shared co-authors 3
University Health Network
Career Start Year 1994
Number of shared co-authors 2
University of Michigan ann arbor
Career Start Year 1991
Number of shared co-authors 2
Rutgers University School of Public Health
Career Start Year 1988
Number of shared co-authors 6
Kaiser Permanente Northern California, University of California san francisco
Career Start Year 1985
Number of shared co-authors 5
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1985
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
University of Texas Health Science Center, School of Public Health at Houston
Career Start Year 1977
Number of shared co-authors 0
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1973
Number of shared co-authors 10
University of California Los Angeles, David Geffen School of Medicine
Career Start Year 1964
Number of shared co-authors 0

Collaborators

Mayo Clinic College of Medicine
Co-authored papers 83
Kaiser Permanente Southern California
Co-authored papers 82
Merck & Co., Inc.
Co-authored papers 57
University of North Carolina at Chapel Hill
Co-authored papers 33
Mayo Clinic
Co-authored papers 32
Mayo Clinic
Co-authored papers 23
Section of Health Services Evaluation, Mayo Clinic
Co-authored papers 19
Brown University, Brown University Warren Alpert Medical School, Dartmouth-Hitchcock Medical Center, Harvard School of Public Health, Johns Hopkins Medicine, Mayo Clinic Minnesota
Co-authored papers 16
Harvard T.H. Chan School of Public Health
Co-authored papers 10
Mayo Clinic
Co-authored papers 8
University of North Carolina at Chapel Hill
Co-authored papers 8
Co-authored papers 7
University of Edinburgh
Co-authored papers 4
Harvard T. H. Chan School of Public Health
Co-authored papers 4
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Epstein Health LLC
Co-authored papers 4
Vagelos College of Physicians and Surgeons, Columbia University
Co-authored papers 4
Co-authored papers 3
University of North Carolina at Chapel Hill
Co-authored papers 3
Co-authored papers 3
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers 3
Co-authored papers 3
Baylor College of Medicine
Co-authored papers 3
Co-authored papers 3
Broad Institute of Harvard and MIT
Co-authored papers 3
Co-authored papers 3